nevirapine has been researched along with Atrophy in 2 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azu, OO | 1 |
| Naidu, EC | 1 |
| Naidu, JS | 1 |
| Masia, T | 1 |
| Nzemande, NF | 1 |
| Chuturgoon, A | 1 |
| Singh, S | 1 |
| Feeney, ER | 1 |
| van Vonderen, MG | 1 |
| Wit, F | 1 |
| Danner, SA | 1 |
| van Agtmael, MA | 1 |
| Villarroya, F | 1 |
| Domingo, P | 1 |
| Capeau, J | 1 |
| Reiss, P | 1 |
| Mallon, PW | 1 |
1 trial available for nevirapine and Atrophy
| Article | Year |
|---|---|
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents | 2012 |
1 other study available for nevirapine and Atrophy
| Article | Year |
|---|---|
Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model.
Topics: alpha-Tocopherol; Animals; Anti-HIV Agents; Antioxidants; Antiretroviral Therapy, Highly Active; Asc | 2014 |